Bio-Rad Laboratories Future Growth
Future criteria checks 0/6
Bio-Rad Laboratories is forecast to grow revenue at 4.1% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Life Sciences earnings growth | 21.7% |
Revenue growth rate | 4.1% |
Future return on equity | 5.4% |
Analyst coverage | Low |
Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 3,084 | N/A | 504 | 643 | 3 |
12/31/2023 | 2,875 | N/A | 517 | 623 | 3 |
12/31/2022 | 2,820 | N/A | 234 | 378 | 3 |
9/30/2022 | 2,805 | -6,035 | 151 | 262 | N/A |
6/30/2022 | 2,871 | -1,942 | 364 | 485 | N/A |
3/31/2022 | 2,896 | -101 | 459 | 589 | N/A |
12/31/2021 | 2,923 | 4,246 | 536 | 657 | N/A |
9/30/2021 | 2,980 | 6,659 | 670 | 783 | N/A |
6/30/2021 | 2,880 | 4,045 | 590 | 689 | N/A |
3/31/2021 | 2,701 | 4,098 | 533 | 626 | N/A |
12/31/2020 | 2,546 | 3,806 | 480 | 575 | N/A |
9/30/2020 | 2,380 | 3,521 | 378 | 450 | N/A |
6/30/2020 | 2,294 | 1,947 | 323 | 414 | N/A |
3/31/2020 | 2,329 | 1,579 | 383 | 478 | N/A |
12/31/2019 | 2,312 | 1,759 | 368 | 458 | N/A |
9/30/2019 | 2,304 | 377 | 272 | 403 | N/A |
6/30/2019 | 2,289 | 905 | 251 | 366 | N/A |
3/31/2019 | 2,292 | 574 | 169 | 288 | N/A |
12/31/2018 | 2,289 | 366 | 156 | 285 | N/A |
9/30/2018 | 2,294 | 1,277 | 148 | 250 | N/A |
6/30/2018 | 2,283 | 1,030 | 116 | 216 | N/A |
3/31/2018 | 2,212 | 767 | 98 | 201 | N/A |
12/31/2017 | 2,160 | 122 | -11 | 104 | N/A |
9/30/2017 | 2,110 | 17 | -4 | 130 | N/A |
6/30/2017 | 2,085 | 13 | -1 | 153 | N/A |
3/31/2017 | 2,097 | 26 | 12 | 168 | N/A |
12/31/2016 | 2,068 | 26 | 74 | 216 | N/A |
9/30/2016 | 2,067 | 98 | 33 | 157 | N/A |
6/30/2016 | 2,028 | 97 | N/A | 188 | N/A |
3/31/2016 | 2,018 | 108 | N/A | 149 | N/A |
12/31/2015 | 2,019 | 109 | N/A | 186 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BUWA's forecast earnings growth is above the savings rate (0.03%).
Earnings vs Market: Insufficient data to determine if BUWA's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if BUWA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: BUWA's revenue (4.1% per year) is forecast to grow slower than the German market (4.6% per year).
High Growth Revenue: BUWA's revenue (4.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BUWA's Return on Equity is forecast to be low in 3 years time (5.4%).